Key Players
Competitive Landscape
The eyelash serums field splits across four business models: dedicated treatment brands, private-label manufacturers, botanical specialists, and broader beauty labels. Companies compete on prostaglandin positioning and eye-area tolerance, while applicator control and local support shape how quickly a formula reaches retail.
A 2025 shift toward gentler formula claims is visible in two specialist launches that moved beyond simple length positioning. BBB London introduced Lash Boost in August 2025 with a 360-degree lash-health proposition covering strength and retention. Skin Balm Apothecary launched Herbal Lash Serum in September 2025 around peptides, biotin, and a hormone-free position. Competition now centers on evidence quality and repeat-use comfort instead of the strongest biological-sounding claim.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| Babe Original introduced Renewing Lash Serum in April 2025 with a peptide-based prostaglandin-free formula. | Sensitive-eye users need treatment choices that avoid ingredients associated with irritation concerns during daily lash-line use. | Peptide systems are gaining visibility as branded alternatives to prostaglandin-oriented growth positioning in direct beauty channels. | Sensitive-eye formulas give specialist brands a higher-trust route into DTC and beauty retail treatment assortments. |
| ZM Beauty Supply opened its UK branch in June 2025 with lash growth serum designated for local rollout. | Private-label brands need faster sample review and packaging decisions before committing to cross-border launch programs. | OEM support is moving closer to European clients through local commercial teams that can shorten development feedback cycles. | Local sampling and compliance support can reduce iteration time for UK and wider European lash-serum launches. |
| Sweed Beauty launched at Credo Beauty in New York in November 2025 with Eyelash Growth Serum in its portfolio. | Premium beauty shoppers increasingly expect treatment products to sit beside clean makeup within the same specialty retail environment. | Lash serums are entering broader premium makeup assortments instead of relying exclusively on specialist treatment channels. | Specialty retail placement gives premium brands another discovery route for serum sales and adjacent eye-makeup purchases. |
RapidLash and RevitaLash remain relevant treatment specialists outside the development table, while Shiseido brings established eye-beauty distribution and formula-development resources.
Source: Future Market Insights, Eyelash Serums Market and Eye Cosmetics Market Reports, 2026-2036.
Together the profiled companies cover specialist treatment formulas, private-label development, sensitive-eye positioning, premium beauty retail, and broader eye-makeup cross-selling.
Who leads the eyelash serums market?
No single company can be verified as the market leader from public primary evidence. Specialist treatment brands and broader beauty groups compete across different price points and channels.
Which suppliers have documented qualification or quality approvals?
Tropic documents ophthalmological testing for Lashful while Babe Original reports ophthalmologist testing for Renewing Lash Serum. Those records give retailers specific eye-area evidence for evaluation.
Which companies provide sensitive-eye or peptide-based products?
Babe Original and Tropic provide prostaglandin-free treatment routes while Skin Balm Apothecary positions Herbal Lash Serum around peptides. Their offers target consumers avoiding stronger hormone-like actives.
Which suppliers serve North America and Europe?
UKLASH sells across the United Kingdom and United States while ZM Beauty Supply established local UK support for European private-label programs. Babe Original also serves North American treatment demand.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Babe Original | Specialist lash brand moving toward peptide-based sensitive-eye treatment formulas. | In April 2025, Babe Original introduced Renewing Lash Serum with a prostaglandin-free peptide formula and ophthalmologist testing. |
| ZM Beauty Supply | OEM/ODM beauty manufacturer supporting private-label lash growth serum development for European programs. | In June 2025, ZM Beauty Supply opened a UK branch and designated lash growth serum as a primary line for local rollout. |
| Skin Balm Apothecary | Botanical beauty specialist positioning lash treatment around peptides and prostaglandin-free formulation. | In September 2025, Skin Balm Apothecary introduced Herbal Lash Serum with peptides, biotin, and a hormone-free position. |
| BBB London | Brow-and-lash specialist extending treatment from length claims toward lash strength and retention. | In August 2025, BBB London introduced Lash Boost as a 360-degree lash serum addressing strength, health, and length. |
| Glow For It Ltd | UK growth-serum brand extending direct sales into major beauty retail distribution. | In March 2025, Glow For It expanded distribution by making its Lash Growth Serum range available through Boots. |
| Sweed Beauty | Premium beauty brand pairing eyelash treatment with clean makeup and specialty retail access. | In November 2025, Sweed Beauty launched at Credo Beauty in New York with Eyelash Growth Serum in its portfolio. |
| UKLASH | Specialist lash-growth brand using major beauty retailers to extend serum discovery beyond direct sales. | In October 2025, UKLASH placed Eyelash Serum in Sephora's beauty advent calendar and Complex Peptide Eyelash Serum in Selfridges' calendar. |
| Tropic Skincare Limited | Community-led beauty brand extending its routine into dedicated cosmetic eyelash treatment. | In July 2026, Tropic Skincare Limited launched Lashful Eyelash Growth Serum with ophthalmological testing for sensitive eyes. |
Research Methodology
The companies mapped here illustrate the eyelash serums market structure instead of an exhaustive ranking. Inclusion requires current verifiable evidence that a company supplies cosmetic eyelash conditioning or appearance-enhancing serum within the defined market scope. Evidence comes from regulatory records, third-party certifications, company announcements, product documentation, and public filings. Capabilities are attributed to the stated lash-serum product family or private-label development line instead of broader beauty portfolios. Market-share estimates remain proprietary FMI assessments for the forecast period.
